𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preoperative and postoperative cytokines in patients with cancer

✍ Scribed by Haruhiro Nakazaki


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
469 KB
Volume
70
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Preoperative and postoperative immunolog
✍ M. Shafir; J. G. Bekesi; A. Papatestas; G. Slater; A. H. Aufses Jr. πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 477 KB πŸ‘ 2 views

Twenty-two patients with cancer of the colon and rectum were studied: preoperative and postoperative cell-mediated and humoral immune factors were assessed, and local concentration of immunoglobulins in tumor tissue and in normal mucosa were measured. Lymphocyte function was found to be reduced in 5

Preoperative or postoperative irradiatio
✍ Alan Rodger; Eleanor D. Montague; Gilbert Fletcher πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 437 KB πŸ‘ 2 views

Results from the standpoint of survival rates and locoregional failures are compared in three series of patients having had a radical mastectomy for breast cancer: (1) radical mastectomy alone for the patients who had essentially outer quadrant lesions and a negative axilla; (2) postoperative irradi

Recent advances in preoperative hyperthe
✍ Saeki, Hiroshi; Kawaguchi, Hidetoshi; Kitamura, Kaoru; Ohno, Shinji; Sugimachi, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 1 views

## Background and objectives: Hyperthermochemoradiotherapy (hcr) has been performed on numerous patients with esophageal cancer. the purpose of this study is to demonstrate the recent advances in hcr. ## Methods: From 1965 to 1997, 294 patients given preoperative chemoradiotherapy (cr) or hcr wer

Preoperative and follow-up procedures on
✍ Edward F. Scanlon; Miguel A. Oviedo; Myles P. Cunningham; Joseph A. Caprini; Jan πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 329 KB πŸ‘ 1 views

194 patients were enrolled in a program under a contract from the NCI to study chemoimmunotherapy in patients with Stage I1 and Stage 111 breast cancer. Patients were treated in six-week cycles for one year and were later followed at six month intervals. Pretreatment evaluation included complete blo